• Sentimag Gen Ad x
  • US KEY Keytruda ADT HCP Update Patient Candidate Banner Ads MT Branded Static x
  • Surgical Oncology Insight Banner Ad x

ADVERTISEMENT

Global Header

H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida

Tampa, Florida

Program Director: Sean Dineen, MD
Assistant Program Director: John Mullinax, MD

H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida building

Moffitt Cancer Center is the only NCI-designated Comprehensive Cancer Center in the state of Florida. The institution has experience remarkable growth since it was established in 1986. There are over 11,000 surgical cases performed each year and over 23,000 new patients seen. The Cancer Center receives more than $70 million in federal and corporate research grants annually.

About the Program

The Complex General Surgical Oncology Fellowship at Moffitt Cancer Center is organized through the University of South Florida ACGME program. The Fellowship is a two-year program, comprised of 18 months of required clinical rotations, four months of research and 2 months of dedicated experience on pathology, radiation oncology and medical oncology. All rotations are at Moffitt facilities. The first clinical year is designed to give all fellows a core exposure to breast, melanoma, sarcoma, endocrine, GI and HPB oncology. This busy clinical year allows fellows to expand their ability to take care of cancer patients in a multidisciplinary fashion. The second year allows for six additional months of clinical training and research time to develop one’s academic endeavors. Fellows may request an optional third year, dedicated to research or to obtaining additional clinical training in specific areas.

Our fellows are exposed to every aspect of Complex General Surgical Oncology. Trainees will see the full spectrum of pathology within each disease site. From a technical standpoint, fellows will gain experience with specialized procedures such as cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC), isolated limb infusion, percutaneous hepatic perfusion, T-VEC and CAR-T. When appropriate, we employ minimally invasive (robotic and laparoscopic) approaches for resection. Our large patient volume also allows for exposure to palliative operations and treatment of complications associated with medical therapy (specifically immunotherapy and bone marrow transplant). Our fellows graduate with an average of 450 cases and easily meet SSO recommended case volumes.
Our departmental structure is unique in that it is disease-site based (Breast, Sarcoma, Cutaneous, and GI Oncology). Thus, the multidisciplinary approach to cancer care is built into the very structure of the program. Each rotation contains a dedicated tumor board with participation from all disciplines including medical oncology, radiation oncology, pathology and diagnostic radiology. This allows the trainee continued exposure to sophisticated, thoughtful discussions of treatment plans.

Clinical teaching occurs continuously while on rotation. Additional didactic teaching sessions are also considered a priority. We have a weekly Morbidity and Mortality conference which covers quality improvement issues and specifically allows fellows to discuss important management decisions which occur during the care of a patient. Additionally, Fellows Conference is a weekly dedicated teaching session during which a fellow presents a specific topic to the group, with a faculty mentor to help highlight the important points during the discussion. These conferences help prepare our fellows for written and oral board examinations.

The last ACGME site visit was in January of 2018. We currently have no citations. The program is approved to graduate 5 fellows per year starting August of 2023. Many of our fellows have become leaders in academic surgical oncologic oncology, but all are experts in the multidisciplinary care of the cancer patient.

Mentoring and Research

The PD and APD meet with all fellows on a quarterly basis. These meetings allow for feedback from trainees and an open dialogue about the training program. From the beginning of fellowship, we start to identify professional interest to help guide each individual to the appropriate position at graduation.

All fellows are expected to participate in research. Research interests are discussed with each fellow at the beginning of the fellowship and at academic productivity meetings. It is expected that fellows will participate in clinical research projects in the first year, as well as begin the background reading and planning that will allow the initiation of a productive research program in the second year. Opportunities exist for the fellows to work with surgical researchers in molecular biology and genetics as well as basic scientists investigating nearly every aspect of human cancer. The third-year research opportunity is encouraged for those with an interest in surgical-scientist positions, but neither mandatory nor guaranteed.

Faculty

Meet Our Team

Eligibility

Applicants must be eligible for a Florida medical license, and be United States citizens or have appropriate visas qualifying them to legally reside in the United States for at least two years.

Number of Positions

5 per year

Deadline

Please visit ERAS to find the deadline.

How to Apply

We accept applications only through the Electronic Residency Application System (ERAS)

Click here for ERAS

Sample Contract

To view a sample contract, please click here.

Salary and Benefits

To view our salary and benefits, please click here.

Contact Information

Training Program Director:Sean Dineen, MD
Assistant Program Director:John Mullinax, MD
Address:H. Lee Moffitt Cancer Center and Research Institute
12902 USF Magnolia Dr, MCC-GME
Tampa FL 33612
Phone:813-745-4787
Program Coordinator:Jeanna Reddy and Beliza Rohena
Email:

Jeanne.Reddy@Moffitt.org

Beliza.Rohena@moffitt.org

Website:www.moffitt.org

For more information about the fellowship, visit our website.

Scroll to Top